Arkolith/Insider Trading/AZYO/Form 4

Mills C Randal

Interim President and CEO, DirectorAZIYO BIOLOGICS, INC. (AZYO) · full profile →Form 4 · filed Jun 23, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 21, 2022Grant(A)274K—$0274K
Jun 21, 2022Grant(A)183K—$0183K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-073897) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML